Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$512M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
| 3 |
Toronto Dominion Bank
TD
|
+$275M |
| 4 |
Shopify
SHOP
|
+$265M |
| 5 |
TC Energy
TRP
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$363M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$202M |
| 3 |
Restaurant Brands International
QSR
|
+$198M |
| 4 |
Canadian Natural Resources
CNQ
|
+$121M |
| 5 |
Invitation Homes
INVH
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.93% |
| 2 | Technology | 14.17% |
| 3 | Miscellaneous | 12.5% |
| 4 | Healthcare | 8.07% |
| 5 | Communication Services | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
BellRing Brands
BRBR
$883M
| $139K | ﹤0.01% |
7,245
+2,854
| +65% | +$53K |
2019 Q4
2 quarters
|
|
2902
City Holding Co
CHCO
$2B
| $139K | ﹤0.01% |
2,338
-5,877
| -72% | -$372K |
2013 Q2
28 quarters
|
|
2903
3D Systems Corp
DDD
$601M
| $139K | ﹤0.01% |
21,482
+15,550
| +262% | +$116K |
2013 Q2
28 quarters
|
|
2904
KALA BIO
KALA
$7.86M
| $139K | ﹤0.01% |
5
+1
| +25% | +$28.3K |
2018 Q2
8 quarters
|
|
2905
Sturm, Ruger & Co
RGR
$704M
| $139K | ﹤0.01% |
1,821
+1,403
| +336% | +$85.3K |
2017 Q2
12 quarters
|
|
|
PRNB
2906
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $139K | ﹤0.01% |
+2,363
| New | +$146K |
2020 Q2
0 quarters
|
|
|
THER
2907
DELISTED
THERATECHNOLOGIES INC COM
THER
| $139K | ﹤0.01% |
61,327
-4,000
| -6% | -$9.07K |
2019 Q4
2 quarters
|
|
|
CHRN
2908
ChronoScale Holdings
CHRN
$2.96B
| $138K | ﹤0.01% |
1,254
+1,200
| +2,222% | +$68.5K |
2016 Q3
15 quarters
|
|
2909
Tucows
TCX
$107M
| $138K | ﹤0.01% |
2,334
-2,216
| -49% | -$123K |
2017 Q3
11 quarters
|
|
|
WIRE
2910
DELISTED
Encore Wire Corp
WIRE
| $138K | ﹤0.01% |
2,995
+534
| +22% | +$24.5K |
2013 Q2
28 quarters
|
|
2911
iShares Core S&P US Growth ETF
IUSG
$34.6B
| $137K | ﹤0.01% |
1,838
-3,970
| -68% | -$264K |
2020 Q1
1 quarter
|
|
2912
Liberty Latin America Class C
LILAK
$1.65B
| $137K | ﹤0.01% |
17,092
+12,445
| +268% | +$106K |
2015 Q3
19 quarters
|
|
|
CVA
2913
DELISTED
Covanta Holding Corporation
CVA
| $137K | ﹤0.01% |
15,392
-182,333
| -92% | -$1.56M |
2013 Q3
27 quarters
|
|
2914
Schwab US Broad Market ETF
SCHB
$44.9B
| $136K | ﹤0.01% |
10,908
+6
| +0.1% | +$69 |
2013 Q2
28 quarters
|
|
|
MAGN
2915
Magnera Corp
MAGN
$410M
| $136K | ﹤0.01% |
701
+311
| +80% | +$59K |
2013 Q2
28 quarters
|
|
2916
Calamos Strategic Total Return Fund
CSQ
$3.29B
| $135K | ﹤0.01% |
10,590
-2,119
| -17% | -$24.3K |
2013 Q2
28 quarters
|
|
2917
Denali Therapeutics
DNLI
$3.22B
| $135K | ﹤0.01% |
5,031
+4,555
| +957% | +$107K |
2019 Q2
4 quarters
|
|
2918
State Street SPDR S&P International Dividend ETF
DWX
$510M
| $135K | ﹤0.01% |
4,043
+1,196
| +42% | +$38.5K |
2019 Q3
3 quarters
|
|
2919
Hyliion Holdings
HYLN
$789M
| $135K | ﹤0.01% |
+5,000
| New | +$60.4K |
2020 Q2
0 quarters
|
|
2920
VanEck Pharmaceutical ETF
PPH
$993M
| $135K | ﹤0.01% |
2,200
-300
| -12% | -$18.1K |
2013 Q2
28 quarters
|
|
2921
Riot Platforms
RIOT
$7.81B
| $135K | ﹤0.01% |
57,600
-25,500
| -31% | -$45.6K |
2018 Q2
8 quarters
|
|
2922
Sinclair Inc
SBGI
$915M
| $135K | ﹤0.01% |
8,031
+3,919
| +95% | +$68K |
2015 Q3
19 quarters
|
|
|
WWE
2923
DELISTED
World Wrestling Entertainment
WWE
| $135K | ﹤0.01% |
2,974
+2,860
| +2,509% | +$123K |
2013 Q2
28 quarters
|
|
|
CORE
2924
DELISTED
Core Mark Holding Co., Inc.
CORE
| $135K | ﹤0.01% |
5,695
+4,341
| +321% | +$116K |
2015 Q3
19 quarters
|
|
2925
Artivion
AORT
$1.09B
| $134K | ﹤0.01% |
7,329
+6,247
| +577% | +$132K |
2015 Q3
19 quarters
|
|
Similar funds
Bank of Montreal's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of Montreal held 4,997 positions worth $110B, up 26% from $87.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of Montreal's Q2 2020 filing shows 847 new, 2,326 increased, 1,132 reduced and 338 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 781,910 shares worth $45.7M. The largest sale was Amazon, an estimated $363M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Miscellaneous.
- Bank of Montreal's largest Q2 2020 buy was iShares AAA-A Rated Corporate Bond ETF: 781,910 shares worth $45.7M.
- Bank of Montreal added most to Mastercard in Q2 2020, an estimated $512M increase.
- Bank of Montreal's biggest Q2 2020 reduction was Amazon, cutting an estimated $363M.
- Bank of Montreal fully exited Allergan plc in Q2 2020, selling an estimated $94M.
- Bank of Montreal's ten largest holdings make up 22% of its $110B portfolio in Q2 2020.
- Bank of Montreal opened 847 new positions and closed 338 in Q2 2020.
- Bank of Montreal's portfolio value rose 26% quarter-over-quarter to $110B.
Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.